At the upcoming European Respiratory Society (ERS) 2022 conference, Fluidda is present with a booth and will be presenting 3 posters. From September 4th – 6th, we will exhibit at the annual conference... View Article
In a recently published systematic literature review, members of PVRI Innovative Drug Development Initiative’s Sequelae of COVID-19 Workstream, including Fluidda CEO Jan De Backer and CSO Ben Lavon, sought to... View Article
New publication on FRI: Assessment of small pulmonary blood vessels in COVID-19 patients using HRCT Mounting evidence supports the role of pulmonary hemodynamic alterations in the pathogenesis of COVID-19. Building... View Article